Skip to main content
Frontiers in Medicine logoLink to Frontiers in Medicine
. 2021 Oct 26;8:785148. doi: 10.3389/fmed.2021.785148

Corrigendum: Development and Characterization of a New Endoscopic Drug-Eluting Platform With Proven Efficacy in Acute and Chronic Experimental Colitis

Ignacio Bon 1, Mary Cano-Sarabia 2, Napoleon de la Ossa 3, Ramon Bartolí 1,4,*,, Vicente Lorenzo-Zúñiga 1,5,*,
PMCID: PMC8577275  PMID: 34765628

There is an error in the Funding statement. Instead of “Health Institute carlos III”, the correct name for the funder is “Instituto de Salud Carlos III (Co-funded by European Regional Development Fund/European Social Fund “A way to make Europe”/“Investing in your future”)”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Medicine are provided here courtesy of Frontiers Media SA

RESOURCES